- Editor's PickYahoo Finance•6 hours ago
Pfizer (PFE) shares remain in the spotlight. The US drug maker that bought cancer drug firm Medivation (MDVN) just a couple of days ago is now buying part of AstraZeneca’s (AZN) antibiotics business. FitBit (FIT) shares got a healthy pop ahead of the open after a US trade judge ruled late Tuesday that the maker of wearable fitness trackers did not steal trade secrets from rival Jawbone.
- Editor's PickNicole Sinclair•2 days ago
On Monday, Medivation (MDVN), which owns Xtandi, confirmed it was being acquired by Pfizer (PFE) for $14 billion. This comes just months after Sanofi (SNY) approached Medivation in a hostile deal, going public with its offer and beginning a process to replace the company’s board. Sanofi lost out on its bid to Pfizer, which was willing to pay up and fold Medivation into its oncology franchise.
Medivation, Inc. (MDVN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||80.25 x 12000|
|Ask||80.26 x 5500|
|Day's Range||80.20 - 80.36|
|52wk Range||26.41 - 80.67|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-74.22|
|Avg Vol (3m)||3,025,346|
|Dividend & Yield||N/A (N/A)|